Abstract
A prospective study of visual acuity (VA) was performed in a cohort of 147 AIDS patients with cytomegalovirus retinitis (CMVR). Patients were treated according to standard regimes, and corrected VA was recorded at regular intervals from presentation until death. Follow-up was 6 weeks to 5 years (mean 30 weeks). Fifty patients (34%) had bilateral CMVR at initial presentation; at death 81 patients (55%) had bilateral disease. Thirty-one eyes initially uninfected developed CMVR during follow-up. Of 228 infected eyes, VA at presentation was 6/12 or better in 182 eyes (80%) and 6/60 or better in 215 eyes (94%) At death, VA was 6/12 or better in 112 eyes (49%) and 6/60 or better in 171 eyes (75%). VA in the better eye at death was 6/12 or better in 113 of 147 patients (77%), 6/24 or better in 135 patients (92%) and worse than 6/60 in only 7 patients (5%). Treatment of AIDS-related CMVR minimises loss of vision and may protect previously uninfected eyes, prolonging visual independence.
Similar content being viewed by others
Article PDF
References
Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY . Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology 1985;92:472–84.
Hansen LL, Nieuwenhuis I, Hoffken G, Heise W . Retinitis in AIDS patients: diagnosis, follow-up and treatment. Fortschr Ophthalmol 1989;86:232–8.
Holland GN, Buhles W Jr, Mastre B, Kaplan HJ . A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardised system for the assessment of disease outcome. UCLA CMV Retinopathy Study Group. Arch Ophthalmol 1989;107:1759–66.
Holland GN, Gottlieb MS, Yee RD, Schanker HM, Pettit TH . Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol 1982;93:393–402.
Studies of Ocular Complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trial Group (ACTG). Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213–20.
Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:185–91.
Leoung GS, Feigal D Jr, Montgomery AB, Corkery K, Wardlaw L, Adams M, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia: the San Francisco community prophylaxis trial. N Engl J Med 1990;323:769–75.
Moore RD, Hidalgo J, Sugland BW, Chaisson RE . Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1412–6.
Palestine AG, Rodrigues MM, Macher AM, Chan CC, Lane HC, Fauci AS, et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology 1984;91:1092–9.
Roarty JD, Fisher EJ, Nussbaum JJ . Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1993;100:1685–8.
Council of State and Territorial Epidemiologists AIDS Program: Center for Infectious Diseases. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;14:1S–15S.
Hall AJ, Jennens ID, Lucas CR, MacLean H, Sandland AM . Low frequency maintenance ganciclovir for cytomegalovirus retinitis. Scand J Infect Dis 1991;23:43–6.
Peters BS, Beck EJ, Anderson S, Coleman D, Coker R, Main J, et al. Cytomegalovirus infection in AIDS: patterns of disease, response to therapy and trends in survival. J Infect 1991;23:129–37.
Kaplan EL, Meier P . Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–81.
Marzuk PM, Tierney H, Tardiff K, Gross EM, Morgan EB, Hsu MA, Mann JJ . Increased risk of suicide in persons with AIDS. JAMA 1988;259:1333–7.
Rajs J, Fugelstad A . Suicide related to human immunodeficiency virus infection in Stockholm. Acta Psychiatr Scand 1992;85:234–9.
Jabs DA, Enger C, Bartlett JG . Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989;107:75–80.
Bloom PA, Graham EM, Migdal CS . Ophthalmic manifestations of HIV disease and AIDS. In: Jay J, Kirkness C, editors. Recent advances in ophthalmology. Edinburgh: Churchill Livingstone, in press.
Gross JG, Bozzette SA, Mathews WC, Spector SA, Abramson IS, McCutchan JA, et al. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1990;97:681–6.
Holland GN, Shuler JD . Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients. Arch Ophthalmol 1992;110:1435–42.
Henderly DE, Freeman WR, Causey DM, Rao NA . Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology 1987;94:425–34.
Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R . Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J AIDS 1992;5:1069–74.
Kuppermann BD, Petty JG, Richman DD, Mathews WC, Fullerton SC, Rickman LS, Freeman WR . Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related non-infectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575–82.
Bachman DM, Bruni LM, DiGioia RA, Harris PJ, McMackin CM, Pistole MC, et al. Visual field testing in the management of cytomegalovirus retinitis. Ophthalmology 1992;99:1393–9.
Harkins T, Maino JH . Cytomegalovirus retinitis complicated by optic neuropathy: a longitudinal study. J Am Optom Assoc 1992;63:21–7.
Quiceno JI, Capparelli E, Sadun AA, Munguia D, Grant I, Listhaus A, et al. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1992;113:8–13.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bloom, P., Sandy, C., Migdal, C. et al. Visual prognosis of AIDS patients with cytomegalovirus retinitis. Eye 9, 697–702 (1995). https://doi.org/10.1038/eye.1995.181
Issue Date:
DOI: https://doi.org/10.1038/eye.1995.181